𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improvement of blepharospasm with Zolpidem

✍ Scribed by Nélida Susana Garretto; José A. Bueri; Roberto D. Rey; Tomoko Arakaki; Gabriela V. Nano; Marcela Mancuso

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
44 KB
Volume
19
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Zolpidem (ZLP) is an imidazopyridine that binds to GABA receptors. We report on improvement of blepharospasm in 3 patients treated with ZLP. The GABAergic action of this drug on the output structures of the basal ganglia could explain the improvement of blepharospasm in these patients. © 2004 Movement Disorder Society

📜 SIMILAR VOLUMES

Botulinum toxin A injections improve apr
Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
✍ Masato Kanazawa; Takayoshi Shimohata; Masahisa Sato; Osamu Onodera; Keiko Tanaka 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Botulinum Toxin A Injections Improve Apraxia of Eyelid Opening without Overt Blepharospasm Associated with Neurodegenerative Diseases Apraxia of eyelid opening (AEO) designates an intermittent inability to open the eyes voluntarily. 1 AEO is observed in patients with neurodegenerative diseases, incl

Botulinum toxin A injections improve apr
Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
✍ Eva Lopez Valdes; Ignacio Javier Posada Rodriguez; Rafael Bilbao-Calabuig 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

We have read with interest the letter of Kanazawa 1 about improvement of apraxia of eyelid opening (AEO) with botulinum toxin A. The term AEO defined as an intermittent inability to open the eyes voluntarily is not a specific entity; it is only a clinical sign whose physiopathological origin is var

Reply: Botulinum toxin A injections impr
Reply: Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
✍ Masato Kanazawa; Takayoshi Shimohata; Masatoyo Nishizawa 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

We have read with interest the letter of Kanazawa 1 about improvement of apraxia of eyelid opening (AEO) with botulinum toxin A. The term AEO defined as an intermittent inability to open the eyes voluntarily is not a specific entity; it is only a clinical sign whose physiopathological origin is var

Successful treatment of the Meige syndro
Successful treatment of the Meige syndrome with oral zolpidem monotherapy
✍ Jae Young An; Joong-Seok Kim; Yeong-In Kim; Kwang Soo Lee 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

Disease Causing Hereditary Late-Onset Ataxia with Only Minimal White Matter Changes: A Report of Two Sibs ataxia. Additional-yet not obligate-clinical features (palatal tremor, kyphoscoliosis) and more or less distinctive MRI findings (subtle white matter changes, marked atrophy of brainstem, and sp